Williams Randall E
Northwestern University School of Medicine, Evanston, IL, and Midwest Heart Specialists, Hoffman Estates, IL 60194, USA.
Prev Cardiol. 2006 Spring;9(2):96-101. doi: 10.1111/j.1520-037x.2006.04690.x.
The use of beta blockers reduces the risk of arrhythmias, reinfarction, and heart failure in both the immediate and long-term periods after a myocardial infarction. Every patient should be prescribed a beta blocker after a myocardial infarction unless there is a strong contraindication to therapy. Despite compelling evidence and recommendations, beta blockers remain an underutilized therapy in the post-myocardial infarction period. Evidence-based recommendations for the choice of agent and the practical implementation of beta blockers are reviewed.
在心肌梗死后的近期和长期，使用β受体阻滞剂可降低心律失常、再梗死和心力衰竭的风险。除非有强烈的治疗禁忌证，心肌梗死后的每位患者都应开具β受体阻滞剂。尽管有确凿的证据和建议，但在心肌梗死后阶段，β受体阻滞剂仍然是一种未得到充分利用的治疗方法。本文综述了关于β受体阻滞剂药物选择的循证推荐以及实际应用情况。
